Interferon response and epigenetic modulation by <i>SMARCA4</i> mutations drive ovarian tumor immunogenicity
Melica Nourmoussavi Brodeur(Centre Hospitalier de l’Université de Montréal), Dmitriy Zamarin(Cornell University)
Cited by 9
Related Papers
PD-L1 in tumor microenvironment mediates resistance to oncolytic immunotherapy
|Journal of Clinical Investigation|2018|148